Cancer

Plus Therapeutics Secures Humana Coverage for CNS Cancer Assay

The agreement extends CNSide cerebrospinal fluid test coverage to 16 million additional patients nationwide.

Cancer

Breath Test Technology Shows Promise for Early Lung Cancer Detection

University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.

Cancer

Study Validating Esophageal Cancer Test Accepted by Gastroenterology Journal

The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.

BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside US

Oct 22, 2025 | Cervical (HPV)

New automated workflow combines at-home sampling with robotic lab processing.

Samsung Invests $110M in GRAIL to Expand Cancer Detection Test in Asia

Oct 17, 2025 | Cancer

Partnership will bring Galleri multi-cancer early detection test to South Korea, with potential expansion to Japan and Singapore.

Proscia Expands AI Capabilities to Support Skin Pathology Evaluation

Oct 15, 2025 | Melanoma

New skin tissue analysis tools aim to address diagnostic challenges in one of pathology’s most diverse specialties.

Circulogene Launches Tissue-Based Genomic Profiling Assay for Solid Tumors

Oct 10, 2025 | Cancer

OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.

Genetic Test Now Available to Predict Radiation Therapy Side Effects in Prostate Cancer

Oct 2, 2025 | Prostate

PROSTOX ultra identifies patients at higher risk of developing late genitourinary toxicity from stereotactic body radiation therapy.

Pancreatic Cancer Study Reaches 10,000 Participants Worldwide

Oct 2, 2025 | Pancreatic

The PRECEDE Consortium doubles its enrollment target to 20,000 as it builds a dataset for early detection tool development.

Prospective Trial Shows PAM50 Biomarker Predicts Hormone Therapy Benefit in Prostate Cancer

Oct 1, 2025 | Prostate

Study finds molecular signature identifies which men with recurrent disease respond to apalutamide plus salvage radiation therapy.

Lab Introduces Self-Collected HPV Test to Enhance Privacy and Access

Oct 1, 2025 | Cervical (HPV)

The new testing option detects 14 high-risk HPV strains without requiring pelvic examination, targeting patients 30 and older with no previous abnormal screenings.

AI-Powered Blood Test Shows Promise for Early Lung Cancer Detection

Oct 1, 2025 | Lung Cancer

A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.

AI-Driven Platform Aims to Bring Personalized Cancer Treatment to More Patients

Sep 29, 2025 | Cancer

First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.

Quest Diagnostics to Expand Blood-Based Colorectal Cancer Screening Access

Sep 26, 2025 | Colorectal

The company is collaborating with Guardant Health to make Guardant’s Shield test available through Quest’s nationwide network of provider clients and patient service centers.

Why Closing Lung Cancer’s Diagnostic Gap Will Require New Lab Strategies

Sep 25, 2025 | Lung Cancer

On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.